Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Bajaj Finserv Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesDivi's Laboratories Limited8.88154727227.3017
Domestic EquitiesSun Pharmaceutical Industries Limited8.444114963425.9570
Domestic EquitiesDr. Reddy's Laboratories Limited7.902621231024.2925
Domestic EquitiesCipla Limited7.823116674624.0481
Domestic EquitiesApollo Hospitals Enterprise Limited5.51232561116.9447
Domestic EquitiesBiocon Limited3.919135256812.0472
Domestic EquitiesPiramal Pharma Limited3.771051577511.5920
Domestic EquitiesSyngene International Limited3.10621314839.5483
Domestic EquitiesNeuland Laboratories Limited2.756470198.4730
Domestic EquitiesTorrent Pharmaceuticals Limited2.5700244747.9001
Domestic EquitiesEmcure Pharmaceuticals Limited2.4811711197.6268
Domestic EquitiesIPCA Laboratories Limited2.4665504837.5820
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited2.1149225716.5012
Domestic EquitiesRainbow Childrens Medicare Limited2.0949459416.4396
Domestic EquitiesHindustan Unilever Limited2.0905284496.4262
Domestic EquitiesGlenmark Pharmaceuticals Limited2.0233403596.2195
Domestic EquitiesSanofi Consumer Healthcare India Limited1.9883126636.1121
Domestic EquitiesAbbott India Limited1.953819556.0059
Domestic EquitiesVijaya Diagnostic Centre Limited1.8626568485.7257
Domestic EquitiesZydus Wellness Limited1.7436318945.3598
Domestic EquitiesOrchid Pharma Limited1.6822666305.1712
Domestic EquitiesPfizer Limited1.6725128395.1414
Domestic EquitiesAlkem Laboratories Limited1.517495554.6645
Domestic EquitiesEmami Limited1.4214753454.3693
Domestic EquitiesLupin Limited1.2929195983.9744
Domestic EquitiesAstraZeneca Pharma India Limited1.272745453.9122
Domestic EquitiesAlembic Pharmaceuticals Limited1.2082399473.7141
Domestic EquitiesDr. Lal Path Labs Limited1.1680144843.5903
Domestic EquitiesMankind Pharma Limited1.1458145263.5222
Domestic EquitiesMarico Limited1.1237530093.4543
Domestic EquitiesMedPlus Health Services Limited1.0973443843.3732
Domestic EquitiesJubilant Pharmova Limited1.0197349863.1344
Domestic EquitiesMedi Assist Healthcare Services Limited0.9333630402.8689
Domestic EquitiesColgate Palmolive (India) Limited0.8727112262.6828
Domestic EquitiesShaily Engineering Plastics Limited0.583198091.7924
Domestic EquitiesNeogen Chemicals Limited0.371674021.1424
Total 93.8884 288.6115
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)4.7565 14.6213
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd3.1933 9.8161
Total 7.9497 24.4374
Derivatives-FuturesDr. Reddy's Laboratories Limited April 2025 Future-1.8381-50000-5.6502
Total -1.8381 -5.6502
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.